Biomed Valley Discoveries, Inc

This study tested whether combining two drugs, ulixertinib and hydroxychloroquine, could help control advanced gastrointestinal cancers that had specific genetic mutations and had stopped responding to standard treatments. It was designed for patients with cancers like pancreatic…